Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Acarbose
Cat. No.:
0225LY-0714
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by HPLC.
Size:
Add to basket
Product Overview
Description:
Acarbose targets alpha-glucosidases to provide antihyperglycemic activity in clinical settings.
Synonym:
56180-94-0; Precose; Prandase; Glucobay; (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
CAS No.:
56180-94-0
Compound CID:
444254
Formula:
C25H43NO18
Formula Weight:
645.6
Specification
Relative Density:
1.4278 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Acarbose can be used in metabolic pharmacology to investigate the regulation of carbohydrate digestion and glucose absorption in the small intestine.
Library Information
Target:
α-Glucosidase
Receptor:
α-Glucosidase
Pathways:
Metabolism
Plate Number:
AOCL-10
Plate Location:
b11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50.00 mg/mL; 77.45 mM
Water Max Solubility:
64.50 mg/mL; 99.91 mM
ALogP:
-6.839
HBA_Count:
5
HBD_Count:
13
Rotatable Bond:
9
